diff --git a/openprescribing/measure_definitions/lptrimipramine.json b/openprescribing/measure_definitions/lptrimipramine.json index 487f583859..b6f3cd25ee 100644 --- a/openprescribing/measure_definitions/lptrimipramine.json +++ b/openprescribing/measure_definitions/lptrimipramine.json @@ -1,17 +1,23 @@ { - "name": "NHS England Low Priority Treatment - trimipramine", - "title": [ - "Trimipramine cost per 1000 patients" - ], - "description": [ - "Cost of trimipramine per 1000 patients" - ], + "name": "Items which should not routinely be prescribed in primary care - trimipramine", + "title": "Trimipramine cost per 1000 patients", + "description": "Cost of trimipramine per 1000 patients", "numerator_short": "Trimipramine cost (£)", "denominator_short": "1000 patients", "why_it_matters": [ - "Trimipramine is an older tricyclic antidepressant. The cost has increased significantly recently, ", - "and there are newer, cheaper alternatives are available, which are ", - " recommended by NICE in preference to tricyclic antidepressants. " + "
", + "NHS England guidance states:
", + "The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.
", + "NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if indicated as they have a more favourable risk-to-benefit ratio ", + "compared to TCAs. However, if a TCA is required, more cost-effective TCAs than trimipramine are available.
", + "Due to the significant cost associated with trimipramine and the availability of alternative treatments, the joint clinical working group considered trimipramine suitable for inclusion in this guidance.
", + "NHS England recommend that GPs:", + "